Navigation Links
Jiangsu in Medical News

Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

...currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion. Access has previously announced that it has licensed ProLindac to jiangsu Aosaikang Pharmaceutical Co., Ltd. ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partner...

MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination

...venture. The name of the joint venture company is "Jiangsu Hualan MIT Medical Technology (MIT China) Ltd" and will be located in Taizhou city in the jiangsu province. This prime location, supported by the central government, will become the most important medical city in China through the relocation of the...

Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013

...n China also finds that increased penetration of current targeted therapies such as AstraZeneca's Iressa (gefitinib), Roche's Tarceva (erlotinib) and jiangsu Simcere's Endostar (endostatin) and the launch of new targeted therapies -- Roche's Avastin (bevacizumab) and Merck KGaA's Erbitux (cetuximab) -- are ...

Chinese Colorectal Cancer Drug Market Will More Than Double by 2012

...provement in access to medical care and significantly increased prescribing of targeted therapies. "The increased use of Merck KGaA's Erbitux and jiangsu Simcere's Endostar and the launch of Roche's Avastin will be the strongest drivers of the Chinese colorectal drug market during the next five years," ...

China-Biotics, Inc. Expands Retail Network to 60 Shining Retail Centers

...roducts are sold over-the-counter under the "Shining" brand through large distributors to more than 1,000 pharmacies and 100 supermarkets in Shanghai, jiangsu and Zhejiang. Shining is one of the most recognized brands in Shanghai. China-Biotics plans to expand its retail sales to other major cities in China ...

Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development

...8 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced that its recently-acquired research institute in the jiangsu Province, the Jiangsu Institute of Microbiology Co., Ltd or "JSIM", is developing a new wide-spectrum antibiotic, Wetimicin, in the People's Republic ...

Chindex International Announces the Opening of Wuxi United Family Healthcare Center

...nghai. The ceremony was attended by Ms. Lu Yanguang, Deputy Director of the jiangsu Entry/Exit Inspection and Quarantine Bureau, Mr. Gong Peixing, a member of ...ing significant convenience to the expatriate families in Wuxi and Southern jiangsu Province, who will gain access to quality medical care at international sta...

China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results

... was also an advanced payment in the amount of RMB13,800,000 (approximately US$1.9 million) made to a organic rice growing project in Donghai, jiangsu Province, in anticipation of a good harvest year. The advance was not utilized because the actual output of the rice was less than expected. T...

Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China

...SE: WYE ) announced today that it is investing $280 million to build a state-of-the-art nutritional manufacturing facility in Suzhou Industrial Park, jiangsu Province, China. The new facility will primarily produce infant formula milk powder and other nutritional products. When completed, the site will be o...

Toxic Algae Pose New Health Scare in China

...s Daily newspaper said. The toxic algae scare in Lake Taihu has already triggered government panic and forced residents of nearby Wuxi city in jiangsu province to turn off contaminated tapwater supplies. Scientists said that algae was still infecting Lake Taihu and had spread to Chaohu Lake in neighb...
Jiangsu in Medical Technology

Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results

...itabine, in multiple solid tumor indications including colorectal and ovarian." Access has previously announced that it has licensed ProLindac to jiangsu Aosaikang Pharmaceutical Co., Ltd. ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partne...

Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.

...c Biopharma Group, Ltd. (PBG), located in San Bruno California and Taizhou, jiangsu Province, People's Republic of China. The transaction was structured as an ...d China Medical City. It is headquartered in San Bruno, CA and in Taizhou, jiangsu Province at the China Medical City complex. NOTE: Other than stateme...
Jiangsu in Medical Dictionary

Potassium hydroxide

...m Hydroxide Information, history, uses and where to buy ... Pure potassium hydroxide forms white, deliquescent crystals. ... Jiangsu, China jiangsu Guangming Chemical Co., Ltd. offers potassium hydroxide . ... We supply high-quality potassium hydroxide , iron content, sulfate content, ... ...
Jiangsu in Biological News

ACS PressPac -- Sept. 17, 2008

...e Contraceptive" DOWNLOAD FULL TEXT ARTICLE http://dx.doi.org/10.1021/pr800259t CONTACT: Jiahao Sha, Ph.D. Nanjing Medical University jiangsu Province, People's Republic of China, 210029 Phone: 86-25-86862908 Fax: 86-25-86862908 Email: shajh@njmu.edu.cn ARTICLE #5 EMBARGOED...
Jiangsu in Biological Technology

Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.

NANJING, China, May 26 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR ), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced an agreement to acquire a 37.5% stake in Jiangsu Yanshen Biologi...

Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region

Transaction Value In Excess of $25 Million; Access Gains Second Source Manufacturing And Significant Clinical Trial Support DALLAS and NANJING, PRC, June 4 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) and Jiangsu Aosaikang Pharmaceutical Co., LTD....

MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners

...e new order show the beginning of a strong commitment and a step towards a successful long-term relationship between MIT and its Chinese partners. jiangsu Hualan MIT Medical Technology (MIT CHINA) Ltd., is actively promoting and selling MIT's unique Agro-Jet(R) needle-free jet injector for animal appli...

Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China

...y produced in China' is the corporate philosophy here which binds us directly to the ambitious objectives for development of the local economy and the jiangsu region," Raster said. At the gala opening he joined Chao Xingsong, the Managing Director of Gerresheimer Danyang, in welcoming representatives from th...

China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility

...ngsu University, Shanghai Jiao Tong University and jiangsu Provincial People's Hospital. Mr. Chen Zhu,...nd abroad. About China Medical City jiangsu Province is considered the number one location for...ated over the past 5 years. The city of Taizhou in jiangsu is not only the hometown of China's President Hu J...

Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting

...bination studies later this year." Access currently has two development and commercialization partners for ProLindac. A licensing agreement with jiangsu Aosaikang Pharmaceutical Co., Ltd. ("ASK") was signed in 2008 under which ASK will manufacture, develop and commercialize ProLindac for the Greater Ch...

Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards

...ifornia, Nanjing Medical University, the China Medical City, Hua Zhong Technical University, the University of Texas Health Science Center at Houston, jiangsu People's Hospital, the No. 2 Hospital of Nanjing Medical University, and the Wu Hu City No. 2 People's Hospital in Anhui, China. These mutual cooperat...

Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million

...rtilizers can be manufactured for farming operations. -- In June, Kiwa and jiangsu Zhongdong Fertilizer Group agreed to develop new compound bio-fertilize...Kiwa Shandong has recently adjusted its product mix in cooperation with jiangsu Zhongdong Fertilizer Group with a focus on developing new compound bio-...

Kiwa Bio-Tech Signs RMB 150 Million (US$21+ million) Fertilizer Contract

...ompany is now applying itself to adjusting its product mix, developing compound fertilizers and other new fertilizer products through cooperation with jiangsu Zhongdong Group. It is expected that before the end of 2008, part of the Agreements will be executed with newly developed products." ABOUT KIWA BIO-...

Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells

...a's Ministry of Science and Technology (MOST), the jiangsu Provincial Department for Science and Technology, ...s attended by MOST officials, the Vice Governor of jiangsu Province Mr. Zhang Taolin, and Taizhou Mayor Mr. Y...ealthcare." About the China Medical City (CMC) jiangsu Province is considered the number one location for...
Other Tags
(Date:12/25/2014)... 2014 This is a professional and ... Sterilizers industry with a focus on the Chinese market. ... of the Sterilizers manufacturers and is a valuable source ... in the industry. This report provides a basic overview ... technology. In this part, the report presents the company ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 ... Market Analysis to 2023” focuses on the current ... opportunities in the colorectal cancer market. Stivarga is ... of colon or rectal cancer. Boehringer Ingelheim is ... for the treatment of refractory CRC in the ...
(Date:12/25/2014)... New York, New York (PRWEB) December 25, 2014 ... of the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ... Liebhard LLP reports. According to an Order issued in ... November 20th, the Court will convene an open conference ... Federal Building and United States Courthouse in West Palm ...
(Date:12/25/2014)... the popular online supplier of wedding dresses and special occasion ... black one-shoulder cocktail dresses . In addition, all these elegant ... prices, up to 70% off. , The development ... You know, we have thousands of frequent callers in the ... can visit our website for more details. The current special ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
(Date:12/17/2014)... Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ... – with the clinical data to back it up," ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
Other Contents